Guy E. Padbury
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
Papers in
-
- Cancer therapeutics and mechanisms 3
- Lipid Membrane Structure and Behavior 1
-
- Synthesis and Biological Evaluation 2
- Co-authors
- Stephen G. Sligar (2 shared papers)Geri A. Sawada (2 shared papers)Barry S. Lutzke (2 shared papers)Thomas J. Raub (4 shared papers)Gary L. Petzold (1 shared paper)Craig L. Barsuhn (1 shared paper)Tanya L. Wallace (1 shared paper)William C. Krueger (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (1 paper)Journal of Biological Chemistry (1 paper)Biochemistry (1 paper)
- Partner nations
- United StatesNetherlandsNorway
In The Last Decade
Guy E. Padbury
15 papers receiving 261 citations
Peers
Comparison fields: 5 of 69
- Toxicology 19
- Oncology 84
- Organic Chemistry 77
- Pharmacology 23
- Molecular Biology 144
Countries citing papers authored by Guy E. Padbury
This map shows the geographic impact of Guy E. Padbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy E. Padbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy E. Padbury more than expected).
Fields of papers citing papers by Guy E. Padbury
This network shows the impact of papers produced by Guy E. Padbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy E. Padbury. The network helps show where Guy E. Padbury may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy E. Padbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. | 1992 | 81 |
| 2 | 1997 | 58 | |
| 3 | 1999 | 54 | |
| 4 | 1988 | 25 | |
| 5 | 1985 | 22 | |
| 6 | 1999 | 8 | |
| 7 | 1996 | 8 | |
| 8 | 1994 | 4 | |
| 9 | 1997 | 3 | |
| 10 | 2011 | 3 | |
| 11 | 1996 | 3 | |
| 12 | 1998 | 2 | |
| 13 | 1996 | 2 | |
| 14 | 1997 | 2 | |
| 15 | 2006 | 1 |
About Guy E. Padbury
Guy E. Padbury is a scholar working on Molecular Biology, Organic Chemistry, Infectious Diseases, Oncology and Pharmacology, having authored 15 papers that have together received 276 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), HIV Research and Treatment (2 papers), Synthesis and Biological Evaluation (2 papers), Lipid Membrane Structure and Behavior (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Toxicology (19 citations), Oncology (84 citations), Organic Chemistry (77 citations), Pharmacology (23 citations) and Molecular Biology (144 citations). Guy E. Padbury has collaborated with scholars based in United States, Netherlands and Norway. Frequent co-authors include Stephen G. Sligar, Geri A. Sawada, Barry S. Lutzke, Thomas J. Raub, Gary L. Petzold, Craig L. Barsuhn, Tanya L. Wallace, William C. Krueger, Norman F.H. Ho and Robert C. Kelly. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical and Biomedical Analysis, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Journal of Biological Chemistry and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.